Skip to content
ClinCalc Pro
Menu
Ocular lubricant

Hypromellose

Brand names: Tears Naturale, Isopto Plain

Hypromellose (hydroxypropyl methylcellulose) is a cellulose-derived ocular lubricant widely used as artificial tears for the symptomatic relief of dry eye and ocular surface dryness.

Dosing — being independently re-sourced

ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.

Clinical monograph

How it works

It is a hydrophilic polymer that increases tear viscosity and forms a stable, moisture-retaining film over the ocular surface, prolonging lubrication of the cornea and conjunctiva.

Prescribing in practice

  • Preserved multidose preparations can cause ocular surface toxicity or irritation with frequent or long-term use, so use a preservative-free product for chronic or frequent dosing or in sensitive patients.
  • Effect is relatively short-lived so frequent instillation may be needed, and it may be used as often as required.
  • Separate the instillation of different eye drops and apply ointments last when more than one product is used.

Monitoring

No systemic monitoring is required; review symptom control and ocular surface health at clinical follow-up.

Counselling the patient

  • Brief blurring of vision is common after each drop, so wait until vision is clear before driving.
  • Do not allow the dropper tip to touch the eye and discard the bottle within the period stated after opening.

Evidence & guidelines

Hypromellose is a long-established first-line artificial tear for dry eye disease in routine ophthalmic practice and NICE Clinical Knowledge Summaries.

Reference: Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).

Related

Curated clinical cross-links plus same-class fallbacks.